These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 1544838)

  • 1. Evaluation of bioreductive drugs in multicell spheroids.
    Durand RE; Olive PL
    Int J Radiat Oncol Biol Phys; 1992; 22(4):689-92. PubMed ID: 1544838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioreductive drugs as post-irradiation sensitizers: comparison of dual function agents with SR 4233 and the mitomycin C analogue EO9.
    Adams GE; Stratford IJ; Edwards HS; Bremner JC; Cole S
    Int J Radiat Oncol Biol Phys; 1992; 22(4):717-20. PubMed ID: 1544844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of three bioreductive drugs (mitomycin C, RSU-1069 and SR4233) on cell lines selected for their sensitivity to mitomycin C or ionising radiation.
    Keohane A; Godden J; Stratford IJ; Adams GE
    Br J Cancer; 1990 May; 61(5):722-6. PubMed ID: 2110815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytotoxicity and DNA lesions produced by mitomycin C and porfiromycin in hypoxic and aerobic EMT6 and Chinese hamster ovary cells.
    Fracasso PM; Sartorelli AC
    Cancer Res; 1986 Aug; 46(8):3939-44. PubMed ID: 3089583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of hypoxia by measurement of DNA damage in individual cells from spheroids and murine tumours exposed to bioreductive drugs. I. Tirapazamine.
    Olive PL
    Br J Cancer; 1995 Mar; 71(3):529-36. PubMed ID: 7880735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioreductive therapy.
    Chaplin DJ
    Int J Radiat Oncol Biol Phys; 1992; 22(4):685-7. PubMed ID: 1544837
    [No Abstract]   [Full Text] [Related]  

  • 7. Detection of hypoxia by measurement of DNA damage in individual cells from spheroids and murine tumours exposed to bioreductive drugs. II. RSU 1069.
    Olive PL
    Br J Cancer; 1995 Mar; 71(3):537-42. PubMed ID: 7880736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioreductive drugs in cancer therapy.
    Stratford IJ
    BJR Suppl; 1992; 24():128-36. PubMed ID: 1341908
    [No Abstract]   [Full Text] [Related]  

  • 9. Bioreductive drugs and the selective induction of tumour hypoxia.
    Bremner JC; Stratford IJ; Bowler J; Adams GE
    Br J Cancer; 1990 May; 61(5):717-21. PubMed ID: 2110814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potentiation of alkylating chemotherapy by dual function nitrofurans in multi-cell spheroids and solid tumors.
    Siemann DW; Sutherland RM
    Radiother Oncol; 1992 Aug; 24(4):239-45. PubMed ID: 1410579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioreductive drugs for cancer therapy: the search for tumor specificity.
    Adams GE; Stratford IJ
    Int J Radiat Oncol Biol Phys; 1994 May; 29(2):231-8. PubMed ID: 8195012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of oncogenicity for bioreductive drugs.
    Hei TK; Piao CQ; He ZY; Hall EJ
    Int J Radiat Oncol Biol Phys; 1992; 22(4):747-50. PubMed ID: 1544847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemosensitization by misonidazole in CCNU-treated spheroids and tumours.
    Durand RE; Chaplin DJ
    Br J Cancer; 1987 Aug; 56(2):103-9. PubMed ID: 3663461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of deficiencies in DNA repair on the toxicity of mitomycin C and porfiromycin to CHO cells under aerobic and hypoxic conditions.
    Hughes CS; Irvin CG; Rockwell S
    Cancer Commun; 1991 Feb; 3(2):29-35. PubMed ID: 1899798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxicity of RSU 1069 in spheroids and murine tumors.
    Olive PL; Durand RE; Chaplin DJ
    Int J Radiat Oncol Biol Phys; 1987 Sep; 13(9):1361-6. PubMed ID: 3624045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual-function 2-nitroimidazoles as hypoxic cell radiosensitizers and bioreductive cytotoxins: in vivo evaluation in KHT murine sarcomas.
    Cole S; Stratford IJ; Adams GE; Fielden EM; Jenkins TC
    Radiat Res; 1990 Oct; 124(1 Suppl):S38-43. PubMed ID: 2236508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioreductive therapies: an overview of drugs and their mechanisms of action.
    Rauth AM; Melo T; Misra V
    Int J Radiat Oncol Biol Phys; 1998 Nov; 42(4):755-62. PubMed ID: 9845091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of the comet assay to identify cells sensitive to tirapazamine in multicell spheroids and tumors in mice.
    Olive PL; Vikse CM; Banath JP
    Cancer Res; 1996 Oct; 56(19):4460-3. PubMed ID: 8813141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioreductive alkylating agent porfiromycin in combination with radiation therapy for the management of squamous cell carcinoma of the head and neck.
    Haffty BG; Son YH; Wilson LD; Papac R; Fischer D; Rockwell S; Sartorelli AC; Ross D; Sasaki CT; Fischer JJ
    Radiat Oncol Investig; 1997; 5(5):235-45. PubMed ID: 9372546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypobaric hypoxia: a method for testing bioreductive drugs in vivo.
    McAleer JJ; McKeown SR; MacManus MP; Lappin TR; Bridges JM
    Int J Radiat Oncol Biol Phys; 1992; 23(3):551-5. PubMed ID: 1612955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.